Skip to main content
Early Breast Cancer
Case-Based Exchanges
Early Breast Cancer Part 3: Adverse Event Management - Patient Case #1
Joyce O’Shaughnessy, MD
Read More
Early Breast Cancer
Case-Based Exchanges
Early Breast Cancer Part 3: Adverse Event Management - Patient Case #2
Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNP
Read More
Early Breast Cancer
Case-Based Exchanges
Early Breast Cancer Part 2: Patient and Caregiver Discussions - Patient Case #1
Joyce O’Shaughnessy, MD
Read More
Early Breast Cancer
Case-Based Exchanges
Early Breast Cancer Part 2: Patient and Caregiver Discussions - Patient Case #2
Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNP
Read More
Online First
Case Reports, Breast Cancer, Tyrosine Kinase Inhibitor, Targeted Therapies
Response to Alectinib in Refractory Breast Cancer With an EML4-ALK Rearrangement
Mikaila Eross, PharmD; Sarah Shockley, PharmD, BCOP; Danielle Roman, PharmD, BCOP; Sarah Miller, DO; Christie Hilton, DO
Read More
Early Breast Cancer
Case-Based Exchanges
Early Breast Cancer Part 1: Identifying Patients - Patient Case #1
Joyce O’Shaughnessy, MD
Read More
Early Breast Cancer
Case-Based Exchanges
Early Breast Cancer Part 1: Identifying Patients - Patient Case #2
Marissa Marti-Smith, DNP, APRN, AGNP-C, AOCNP
Read More
Managing Side Effects of Antibody–Drug Conjugate (ADC) Therapy: A Guide for Patients With Metastatic Breast Cancer
Read More
Online First
Case Reports, Adverse Events, Drug–Drug Interaction, Breast Cancer
Simvastatin-Induced Rhabdomyolysis Potentially Triggered by Palbociclib Inhibition of CYP3A4: A Case Report
Madeleine Hosick, PharmD; Karam Abi Karam, DO; Kaitlyn Korah, PharmD; Kyla Bidne, PharmD, BCOP; Diana Tamer, PharmD, BCOP
Read More
Original Research, Adverse Events, Dose Escalation/Reduction, Cost of Care
Calcitonin Dosing for Hypercalcemia of Malignancy
Sandra Savaya, PharmD, BCOP; Christan Mychajlonka, PharmD, BCOP; John Radosevich, PharmD; Asad Patanwala, PharmD, MPH
Read More
Page 10 of 199
Results 91 - 100 of 1986